日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cell-penetrating antibody enhances nuclear delivery of triplex-forming oligonucleotides targeting HER2-positive cancers

细胞穿透抗体增强靶向HER2阳性癌症的三链寡核苷酸的核递送

Minnah, Anthony; García Tubéns, Nicole M; Krysztofiak, Adam; Liu, Yanfeng; Glazer, Peter M; Rogers, Faye A

PARP inhibitor resistance in IDH1-mutant cancers due to loss of end protection factors, 53BP1 and REV7.

IDH1 突变癌症中 PARP 抑制剂耐药性是由于末端保护因子 53BP1 和 REV7 的缺失所致。

Colón-Ríos Daniel Andrés, Dow Jonathan, Krysztofiak Adam, Liu Yanfeng, Rogers Faye A, Glazer Peter M

Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases

含修饰鸟嘌呤碱基的富含G的三链体寡核苷酸的生物活性得到改善

Rogers, Faye A; Lloyd, Janice A; Tiwari, Meetu Kaushik

Local delivery of gene-modifying triplex-forming molecules to the epidermis

将基因修饰三链体形成分子局部递送至表皮

Rogers, Faye A; Hu, Rong-Hua; Milstone, Leonard M

Targeted correction of a thalassemia-associated beta-globin mutation induced by pseudo-complementary peptide nucleic acids

利用假互补肽核酸靶向纠正地中海贫血相关β-珠蛋白突变

Lonkar, Pallavi; Kim, Ki-Hyun; Kuan, Jean Y; Chin, Joanna Y; Rogers, Faye A; Knauert, Melissa P; Kole, Ryszard; Nielsen, Peter E; Glazer, Peter M

Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides

利用三链体形成寡核苷酸进行染色体基因靶向的肽缀合物

Rogers, Faye A; Manoharan, Muthiah; Rabinovitch, Peter; Ward, David C; Glazer, Peter M